Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News bluebird bio Inc BLUE

Healthcare Biotechnology
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BLUE)

bluebird bio Announces Receipt of Expected Notice from Nasdaq

Business Wire 1 hour ago

bluebird bio, Inc. Class Action: Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE

Accesswire 3 hours ago

Shareholders that Lost Money on bluebird bio, Inc.(BLUE) Should Contact Levi & Korsinsky About Pending Class Action - BLUE

Accesswire 3 hours ago

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm

Accesswire 3 hours ago

BLUE LAWSUIT ALERT: Levi & Korsinsky Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire 4 hours ago

Shareholders that lost money on bluebird bio, Inc. (BLUE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire 4 hours ago

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm

Newsfile 5 hours ago

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE

Accesswire 5 hours ago

bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE

Accesswire 5 hours ago
View More News ››

Opinion & Analysis (NDAQ:BLUE)

Coverage Initiated on Cancer Vaccine Firm

Streetwise Reports March 11, 2019

Risk Versus Reward: The Value of Cell Therapy for Patients and Investors

Streetwise Reports April 25, 2018

Partnerships propel Stellar Biotechnologies' vaccine technology

The Life Sciences Report June 22, 2016

CAR T-cell therapeutics: Alan Leong of BioWatch looks beyond the buzz for solid early-stage plays

Gail Dutton September 10, 2015

Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

George S. Mack September 3, 2015

Zacks' Jason Napodano is not focused on a biotech bubble

George S. Mack July 9, 2015
View More Opinion ››

Bullboard Posts (NDAQ:BLUE)

"durable disease remissions for up to 5 years"

https://www.medscape.com/viewarticle/sickle-cell-gene-therapy-truly-transformative-2023a1000uso
Quint13 - December 14, 2023

Approved Dec 8

https://www.businesswire.com/news/home/20231209650405/en/Long-term-Follow-up-Data-From-bluebird%E2%80%99s-Gene-Therapy-Program-in-Sickle...
Quint13 - December 9, 2023

RE:TD WATERHOUSE TOP 10 IN BIOTECHNOLOGY STOCKS

They should add EDT and SQD to their list .... like around the top. IMHO
inspecthrgadget - July 9, 2020

TD WATERHOUSE TOP 10 IN BIOTECHNOLOGY STOCKS

TD WATERHOUSE TOP 10 IN BIOTECHNOLOGY STOCKS Top 10 : 1.TRIL 2. BU 3. IBT 4. MDNA 5. APS 6. GENX 7. BLU 8. MBX 9. ARCH 10. MIR
TheBearInTheWoods - May 9, 2020

RE:RE:Amazing cure for bladder / brain cancer with laser tech

GRAMPS1996 - August 27, 2018

RE:Amazing cure for bladder / brain cancer with laser tech

An interesting Canadian company brother love. Difficult finding info. Found some news on yahoo.  Will keep an eye on it. 
norjase - August 27, 2018
View more Bullboard ››

Geologica Resource Corp.

Geologica Resource Corp.

Geologica Resource Corp. is an exploration and development company focused on the acquisition, exploration and development of ...
View More »